Acetazolamide
- Product NDC
- 50090-5217
- 11-digit product format
- 500905217
- Labeler code
- 50090
- Product ID
- 50090-5217_e6d76073-65fd-4d9a-ac8b-36cab930b01a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA211556
- Marketing category
- ANDA
- Marketing start
- 2020-01-30
- Marketing end
- 0000-00-00
- Substance
- ACETAZOLAMIDE
- Active strength
- 125 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5217-1 | 50090521701 | 12 TABLET in 1 BOTTLE (50090-5217-1) | 12 tablet | 2020-10-06 | 0000-00-00 | No | No | Current |